Community Healthcare(CHCT)
$15.01-0.26 (-1.70%)
CHCT
Community Healthcare financials statements
$15.01
At close:-0.26 (-1.70%)
Want to see CHCT full AI Analyst Report?
Community Healthcare (CHCT) Ratios
352 Followers
Community Healthcare Ratios
CHCT's free cash flow for Q3 2026 was $9.15M. For the 2026 fiscal year, CHCT's free cash flow was decreased by $-4.72M and operating cash flow was $13.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.17 | 0.25 | 5.74 | 4.39 | 1.98 |
| Quick Ratio | 0.17 | 0.25 | 5.74 | 4.39 | 1.98 |
| Cash Ratio | 0.01 | 0.02 | 0.29 | 0.74 | 0.10 |
| Solvency Ratio | 0.09 | 0.08 | 0.11 | 0.15 | 0.18 |
| Operating Cash Flow Ratio | 0.20 | 0.25 | 5.02 | 3.96 | 2.38 |
| Short-Term Operating Cash Flow Coverage | 0.22 | 0.28 | 12.35 | 0.00 | 4.70 |
| Net Current Asset Value | $ -513.92M | $ -458.49M | $ -361.93M | $ -312.71M | $ -245.44M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.54 | 0.49 | 0.44 | 0.41 | 0.36 |
| Debt-to-Equity Ratio | 1.25 | 1.03 | 0.80 | 0.72 | 0.58 |
| Debt-to-Capital Ratio | 0.56 | 0.51 | 0.45 | 0.42 | 0.37 |
| Long-Term Debt-to-Capital Ratio | 0.39 | 0.37 | 0.44 | 0.42 | 0.35 |
| Financial Leverage Ratio | 2.31 | 2.09 | 1.84 | 1.76 | 1.63 |
| Debt Service Coverage Ratio | 0.28 | 0.27 | 2.90 | 5.65 | 2.85 |
| Interest Coverage Ratio | 0.60 | 0.85 | 1.41 | 2.85 | 3.12 |
| Debt to Market Cap | 1.21 | 0.95 | 0.61 | 0.42 | 0.24 |
| Interest Debt Per Share | 21.23 | 19.36 | 17.06 | 15.61 | 12.03 |
| Net Debt to EBITDA | 6.44 | 7.56 | 6.17 | 5.15 | 4.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.66% | 80.28% | 81.64% | 82.97% | 83.27% |
| EBIT Margin | 32.32% | 17.73% | 22.87% | 34.74% | 36.65% |
| EBITDA Margin | 68.25% | 55.47% | 58.71% | 68.72% | 71.13% |
| Operating Profit Margin | 16.72% | 17.37% | 22.24% | 34.67% | 36.33% |
| Pretax Profit Margin | 4.23% | -2.75% | 7.11% | 22.58% | 25.02% |
| Net Profit Margin | 4.21% | -2.75% | 6.84% | 22.54% | 24.83% |
| Continuous Operations Profit Margin | 4.21% | -2.75% | 6.84% | 22.54% | 24.83% |
| Net Income Per EBT | 99.55% | 100.00% | 96.18% | 99.81% | 99.26% |
| EBT Per EBIT | 25.29% | -15.81% | 31.95% | 65.14% | 68.86% |
| Return on Assets (ROA) | 0.51% | -0.32% | 0.82% | 2.51% | 2.98% |
| Return on Equity (ROE) | 1.19% | -0.67% | 1.50% | 4.43% | 4.87% |
| Return on Capital Employed (ROCE) | 2.85% | 2.65% | 2.69% | 3.93% | 4.50% |
| Return on Invested Capital (ROIC) | 2.08% | 2.07% | 2.63% | 3.93% | 4.40% |
| Return on Tangible Assets | 0.52% | -0.32% | 0.82% | 2.52% | 2.98% |
| Earnings Yield | 1.16% | -0.62% | 1.15% | 2.60% | 2.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.25 | 2.56 | 1.98 | 1.81 | 2.10 |
| Payables Turnover | 0.00 | 0.00 | 1.72 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 39.93 | 37.05 | 0.13 | 29.56 | 34.08 |
| Asset Turnover | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
| Working Capital Turnover Ratio | -0.60 | -1.98 | 2.06 | 2.61 | 13.34 |
| Cash Conversion Cycle | 112.32 | 142.81 | -27.89 | 201.22 | 173.74 |
| Days of Sales Outstanding | 112.32 | 142.81 | 184.14 | 201.22 | 173.74 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 212.03 | 0.00 | 0.00 |
| Operating Cycle | 112.32 | 142.81 | 184.14 | 201.22 | 173.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.10 | 2.22 | 2.44 | 2.55 | 2.42 |
| Free Cash Flow Per Share | 1.34 | 1.29 | 1.68 | 2.11 | 2.11 |
| Dividend Paid and CapEx Coverage Ratio | 0.76 | 0.77 | 0.92 | 1.10 | 1.14 |
| Capital Expenditure Coverage Ratio | 2.75 | 2.39 | 3.23 | 5.81 | 7.81 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.12 | 0.15 | 0.17 | 0.21 |
| Operating Cash Flow to Sales Ratio | 0.47 | 0.51 | 0.54 | 0.62 | 0.62 |
| Free Cash Flow Yield | 8.14% | 6.72% | 6.32% | 5.90% | 4.47% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 212.14 | -160.21 | 87.03 | 38.42 | 48.89 |
| Price-to-Sales (P/S) Ratio | 3.64 | 4.40 | 5.95 | 8.66 | 12.14 |
| Price-to-Book (P/B) Ratio | 1.03 | 1.07 | 1.31 | 1.70 | 2.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.28 | 14.89 | 15.83 | 16.95 | 22.38 |
| Price-to-Operating Cash Flow Ratio | 7.81 | 8.66 | 10.94 | 14.03 | 19.52 |
| Price-to-Earnings Growth (PEG) Ratio | -1.59 | 0.75 | -1.16 | -5.57 | 5.59 |
| Enterprise Value Multiple | 11.77 | 15.49 | 16.30 | 17.76 | 21.21 |
| Enterprise Value | 973.85M | 995.24M | 1.08B | 1.19B | 1.37B |
| EV to EBITDA | 11.77 | 15.49 | 16.30 | 17.76 | 21.21 |
| EV to Sales | 8.04 | 8.60 | 9.57 | 12.20 | 15.09 |
| EV to Free Cash Flow | 27.12 | 29.07 | 25.47 | 23.88 | 27.82 |
| EV to Operating Cash Flow | 17.26 | 16.90 | 17.60 | 19.77 | 24.25 |
| Tangible Book Value Per Share | 15.94 | 17.87 | 20.26 | 20.92 | 19.84 |
| Shareholders’ Equity Per Share | 15.99 | 17.94 | 20.37 | 21.02 | 19.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.04 | 0.00 | 0.01 |
| Revenue Per Share | 4.51 | 4.36 | 4.48 | 4.13 | 3.89 |
| Net Income Per Share | 0.19 | -0.12 | 0.31 | 0.93 | 0.97 |
| Tax Burden | 1.00 | 1.00 | 0.96 | 1.00 | 0.99 |
| Interest Burden | 0.13 | -0.15 | 0.31 | 0.65 | 0.68 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.21 | 0.16 | 0.24 | 0.15 | 0.13 |
| Stock-Based Compensation to Revenue | 0.09 | 0.09 | 0.18 | 0.10 | 0.08 |
| Income Quality | 11.06 | -18.51 | 7.96 | 2.74 | 2.51 |
Currency in USD
